Covid-19

Zhang, C. X., Boukari, Y., Pathak, N., Mathur, R., Katikireddi, S. V., Patel, P., et al. (2022). Migrants' primary care utilisation before and during the COVID-19 pandemic in England: An interrupted time series analysis. Lancet Reg Health Eur, 20, 100455. http://doi.org/10.1016/j.lanepe.2022.100455
Impara, E., Bakolis, I., B├ęcares, L., Dasch, H., Dregan, A., Dyer, J., et al. (2022). COVID-19 ethnic inequalities in mental health and multimorbidities: protocol for the COVEIMM study. Soc Psychiatry Psychiatr Epidemiol, 1-11. http://doi.org/10.1007/s00127-022-02305-y
Gulliford, M. C., Prevost, A. T., Clegg, A., & Rezel-Potts, E. (2022). Mortality of Care Home Residents and Community-Dwelling Controls During the COVID-19 Pandemic in 2020: Matched Cohort Study. J Am Med Dir Assoc, 23, 923-929.e2. http://doi.org/10.1016/j.jamda.2022.04.003
Gulliford, M. C., Prevost, A. T., Clegg, A., & Rezel-Potts, E. (2022). Mortality of Care Home Residents and Community-Dwelling Controls During the COVID-19 Pandemic in 2020: Matched Cohort Study. J Am Med Dir Assoc, 23, 923-929.e2. http://doi.org/10.1016/j.jamda.2022.04.003
Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., et al. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419
Haroon, S., Nirantharakumar, K., Hughes, S. E., Subramanian, A., Aiyegbusi, O. L., Davies, E. H., et al. (2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413